. Two novel tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce tau pathology. J Biol Chem. 2013 Nov 15;288(46):33081-95. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. An important study emphasising the validity of a tau-based immunotherapeutic approach in AD.